Point72 Asset Management, L.P.

Position in AZN — Astrazeneca PLC

CIK 1603466 STAMFORD, CT

Back to AZN Full portfolio

Position in AZN

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$134,923,542

-$108,439,035 QoQ

Shares Held

711,547

-42.3% QoQ

Ownership

0.046%

of shares outstanding

% of Portfolio

0.22%

of 13F equity value

Holder Rank

#110

of 1,459 holders

Holding Since

Mar 2026

2 quarters on record

Voting authority Sole 0% Shared 100% None 0%

Common Shares in AZN Over Time

Shares Held

Position Value (USD)

Derivatives in AZN

reported options exposure · as of Jun 30, 2026

CallValue

$2,246,997

CallShares

11,850

PutValue

$3,896,691

PutShares

20,550

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Point72 Asset Management, L.P. holds $681,590,231 across 11 Drug Manufacturers - General names. AZN ranks #3 (19.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	GILD	Gilead Sciences, Inc.	1,437,685	$181,637,122
2	GSK	GSK plc	2,652,881	$139,064,022
3	AZN	Astrazeneca PLC This page	711,547	$134,923,542
4	ABBV	AbbVie Inc.	366,836	$92,310,611
5	MRK	Merck & Co., Inc.	380,081	$48,840,408
6	SNY	Sanofi	820,078	$34,984,527
7	BIIB	Biogen Inc.	88,149	$19,045,472
8	NVS	Novartis AG	106,157	$16,636,925

All Filings in AZN

Export CSV

6 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,246,997	11,850	+7.2%	Call	Defined	2026-08-14
2026-06-30	$3,896,691	20,550	+0.5%	Put	Defined	2026-08-14
2026-06-30	$134,923,542	711,547	-42.3%	Shares	Defined	2026-08-14
2026-03-31	$4,033,149	20,450	—	Put	Defined	2026-05-15
2026-03-31	$2,179,281	11,050	—	Call	Defined	2026-05-15
2026-03-31	$243,362,577	1,233,965	—	Shares	Defined	2026-05-15
No filing history on record for this holder in this stock.